These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35832243)

  • 1. Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan.
    Li W; Sun Y; Xu N
    Comput Intell Neurosci; 2022; 2022():2368155. PubMed ID: 35832243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
    Ren Z; Ding HM; Qian X; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of autoantibody detection in the diagnosis and staging of lung cancer.
    Wang Y; Jiao Y; Ding CM; Sun WZ
    Ann Transl Med; 2021 Nov; 9(22):1673. PubMed ID: 34988182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
    Chen P; Lu W; Chen T
    J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
    Mu Y; Li J; Xie F; Xu L; Xu G
    J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer.
    Mu Y; Xie F; Sun T
    J Clin Lab Anal; 2020 Aug; 34(8):e23349. PubMed ID: 32372513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
    Ma H; Wu T; Zhang Q; Ding Q
    BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic efficiency of seven autoantibodies in lung cancer.
    Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
    Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.
    Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M
    Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of combined detection of seven lung cancer-related autoantibodies in assisting the diagnosis of non-small-cell lung cancer.
    Chen G; Guo P; Zhao H; Zhao D; Yang D
    Biomark Med; 2024; 18(20):917-925. PubMed ID: 39360656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
    Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
    PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of seven autoantibodies in lung cancer diagnosis.
    Luo B; Mao G; Ma H; Chen S
    J Thorac Dis; 2021 Jun; 13(6):3660-3668. PubMed ID: 34277058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
    Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography].
    Meng QC; Gao PR; Ren PF; Song YP; Li HL
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):204-208. PubMed ID: 30669764
    [No Abstract]   [Full Text] [Related]  

  • 16. An analysis of the influencing factors of false negative autoantibodies in patients with non-small cell lung cancer.
    Wang A; Hao Y; Huo Y; Xu X; Zhang Y
    Front Oncol; 2024; 14():1358387. PubMed ID: 38800369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome.
    Li S; Ma Y; Xiong Y; Zhang P; Wang X; Wang Y; Yang Y
    Transl Cancer Res; 2019 Aug; 8(4):1364-1373. PubMed ID: 35116879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validation of an autoantibody test for lung cancer.
    Boyle P; Chapman CJ; Holdenrieder S; Murray A; Robertson C; Wood WC; Maddison P; Healey G; Fairley GH; Barnes AC; Robertson JF
    Ann Oncol; 2011 Feb; 22(2):383-9. PubMed ID: 20675559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.
    Chapman CJ; Healey GF; Murray A; Boyle P; Robertson C; Peek LJ; Allen J; Thorpe AJ; Hamilton-Fairley G; Parsy-Kowalska CB; MacDonald IK; Jewell W; Maddison P; Robertson JF
    Tumour Biol; 2012 Oct; 33(5):1319-26. PubMed ID: 22492236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of lung cancer by using an autoantibody panel in Chinese population.
    Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR
    Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.